Diabetic Under 70 (Diabetics Below 70)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 685
- 试验地点
- 1
- 主要终点
- Cholesterol levels
研究概览
简要总结
A screening project of diabetics with a very high cardiovascular risk (e.g. diabetes plus coronary heart disease) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is <70mg/dl for such patients with very high risk) are screened. The doctors therapy decisions after the screening will be documented and 8-10 weeks later the lipid profile of each patient will be evaluated again. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.) who already receive cholesterol-lowering therapy
排除标准
- •Diabetics w/o CVD; diabetics who do not receive cholesterol-lowering therapy
结局指标
主要结局
Cholesterol levels
时间窗: After 4 weeks
Cholesterol levels from high risk patients after 4 weeks of cholesterol-lowering drug therapy under target values
次要结局
未报告次要终点